The Web Health


Umeclidinium and Vilanterol

Generic name: [ue-ME-kli-DIN-ee-um-and-vye-LAN-ter-ol]umeclidinium and vilanterol

Brand name: Anoro Ellipta
Form of dosage: inhalation powder (62.5 mg/25 milligrams/inh)
Drug class: bronchodilator combinations

What are Umeclidinium and Vilanterol?

Umeclidinium and vilanterol are combination medicines that are used to prevent obstruction of airflow and to reduce flare-ups among adults suffering from COPD (chronic obstructive pulmonary disease), which includes asthma and emphysema.

Umeclidinium and vilanterol are intended to be used only by people with COPD. It is not recommended to treat asthma.Umeclidinium as well as vilanterol could be used to treat conditions not covered in this medication guide.

Side effects of Umeclidinium and Vilanterol

See a doctor immediately. Get medical attention immediately if you notice symptoms or warning signs of an allergic response, such as symptoms of hives, difficulty breathing, or swelling of your lips, face, and tongue.

Umeclidinium and vilanterol can cause severe adverse effects. Consult your doctor immediately. If you suffer from:

  • Wheezing or choking, or other breathing issues following the use of this medicine.
  • Urination that is painful or difficult, or having to urinate more frequently;
  • Blurred vision blurred vision, redness or pain, or the appearance of halos around lights
  • Increased blood sugar, increased thirst or urination, hunger, dry mouth, or breath odor that smells like fruit or
  • Low potassium level: leg cramps, constipation, irregular heartbeats, the chest fluttering and tingling or numbness, and muscles becoming weak or sluggish.

Common adverse effects of umeclidinium as well as vilanterol could include:

  • Nasal congestion, sinus pain, sore throat;
  • Discomfort in the chest; cough;
  • Diarrhea, constipation;
  • Muscles spasms muscle spasms;
  • Discomfort in your neck or in your arms.

This isn't an exhaustive list of possible side effects, and others could happen. Consult your physician to seek medical advice on the effects. You can report adverse reactions to the FDA at 1-800-FDA-1088.

Similar or related drugs

Prednisone, Symbicort, Breo Ellipta, Ventolin, Spiriva, Ventolin HFA, and Anoro Ellipta


It is not recommended to use umeclidinium and vilanterol if you are allergic to either or if you suffer from an extreme allergic reaction to milk proteins.Umeclidinium and vilanterol are not cure-all medicines. It is not fast enough to treat an attack of bronchospasm.

Get medical attention. If your breathing problems don't improve or if symptoms become worse rapidly,

Prior to use this drug

It is not recommended to use this medicine if you're allergic to vilanterol or umeclidinium or if you suffer from an extreme sensitization to dairy proteins.

Speak to your doctor if you were ever diagnosed with:

  • Heart disease, high blood pressure;
  • A seizure;
  • Liver disease;
  • Glaucoma;
  • Diabetes;
  • A thyroid disorder;
  • An enlarged prostate or urination issues.

Inform your doctor if you are nursing or pregnant.Umeclidinium and vilanterol are not permitted for use by anyone less than 18 years old.

How to take Umeclidinium and vilanterol?

Follow the instructions on the label of your prescription and read the medication guide. Make sure you use the medicine precisely as directed.Umeclidinium and vilanterol are not cures for bronchospasm. Use only fast-acting inhalation medication for an attack. Get medical attention if breathing issues get worse rapidly or if you suspect the medications you are taking aren't effective enough.

Be sure to read and adhere to any instructions for use that are included with your medicine. Talk to your pharmacist or doctor for clarification if you are unsure of these directions.Make sure to take the medication at the same time every day, but not more than twice in the course of a 24-hour time period.

Keep it at room temperature, far from heat, moisture, and light. Place the inhaler inside the foil tray until it is ready to use.Toss the inhaler out six weeks after opening or until the dose indicator shows zero (whichever occurs first).

Details on dosage

Usual Adult Dose for Chronic Obstructive Pulmonary Disease—Maintenance:

Inhalation of one dose (umeclidinium 62.5 mg and vilanterol 25 mcg) orally, once per day
Maximum dose: one inhalation every 24 hours
Utilization: Long-term treatment of obstruction to airflow for patients suffering from chronic obstructive lung disease (COPD) that includes chronic bronchitis or emphysema

What happens if I miss the dose?

Utilize the medicine as soon as you are able, but take a break from any missed doses if it's close to the time for the next dose. Don't take two doses at once. Don't use more than one dose in the span of 24 hours.

What happens if I overdose?

Get medical attention in an emergency or contact the poison help line at 1-800-222-1222.

The symptoms of an overdose can include the following: headache or chest pain, rapid heart rate, tremors, and feeling nervous or shaky.

What should be avoided?

Do not take a second inhaled bronchodilator containing arformoterol, formoterol, olodaterol, salmeterol, or vilanterol.

Interaction with other drugs

Discuss with your doctor any other medications you take, including:

  • Atropine;
  • Antifungal, antiviral medicine;
  • Monoamine oxidase inhibitors, tricyclic antidepressants, and medications that lengthen the QT interval
  • Beta-blockers;
  • Medications for treating the symptoms of depression, anxiety, mood disorders, depression, or mental illness
  • Cold or allergy medicine (Benadryl and other brands);
  • Medicines used to cure patients suffering from Parkinson's disease;
  • Medicine to treat stomach disorders, motion sickness, and IBS;
  • Medicines to treat an overactive bladder treatment for overactive bladder
  • Another bronchodilator drug

This list isn't exhaustive. Other medications may interact with umeclidinium or vilanterol, such as prescription and over-the-counter medicines, vitamins, and herbal remedies. The interactions between these drugs are not included in this guideline for medication.